ArticlePharmacoepidemiology and drug safety2025

Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Among Type 2 Diabetes Patients: Replication and Reliability Assessment Across a Research Network.

Mitchell M Conover et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.